XENE earnings: a positive outcome, +5.5%

On November 5, 2020, Xenon Pharmaceuticals Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.5% in the window around the event. It had already run -12.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.